An exclusive blog, sponsored by Loftware, devoted to labeling issues that affect your business in an ever-changing global economy.
Posts tagged "C-Level Issues"

A ground-breaking white paper: Compliance with UDI Labeling Mandates: A Proven Methodology

We have a brand new and very compelling White Paper just out. Compliance with UDI Labeling Mandates: A Proven Methodology, was produced because, as the introduction states: There has never been a better or more urgent time for manufacturers of healthcare products to make a close examination of their product labeling systems. If you read...

GS1 Hong Kong Supply Chain Management Excellence Summit Update

Webnewswire is carrying the text of a speech delivered at the GS1 Hong Kong Supply Chain Management Excellence Summit 2009 by Rita Lau. She is Hong Kong’s Secretary for Commerce and Economic Development.  

VHA Asks FDA for Speedy UDI Decision; Inclusion of Only GS1 Standards as Single Mandatory Solution

This news comes from Healthcare Purchasing News:  VHA Inc. and 13 of its largest health system members have sent a letter to the U.S. Food & Drug Administration requesting prompt issuance of Unique Device Identification (UDI) regulations, and that those regulations include  GS1 supply chain standards. At this link, you can see the full release direct...

GS1 Canada's Basic Store Checkout Product Recall Safeguard Featured by the Country's Largest Daily Newspaper — Will "High-Tech Healthcare" Ever Get This?

Dana Flavelle, writing for the Toronto Star has brought mainstream media attention to GS1 Canada’s roll out of a solution that lets consumers learn of product recalls at the store checkout. The story carries the headline, “Product recalls soon to be listed at checkout.”  

Emerging Markets to Save Sanofi-Aventis from Urgent Merger Says CEO – Yet More EML Required!

The French newspaper Le Monde conducted an extensive interview with Sanofi-Aventis Chief Executive Chris Viehbacher about the drug company’s economic survival and whether or not a mega-merger is in order to achieve financial stability.  The whole interview isn’t yet available, but in this Dow Jones report about an advance copy, six specific things  are cited by Mr....

India's Booming Emerging Medical Device Market and the GS1 Connection: GS1 Compliant EML

Here’s a summary of recent research showing the current and future expected growth of the medical device market in India. It features plenty of stats, all upward trending and at a good velocity, but it was this statement that interested me the most: The medical devices and equipments market is poised for phenomenal growth due...

GS1 Australia Initiative Aims to Unite Consumer Electronics Retailers and Suppliers over eCommence Standard

A newly formed organization called the Consumer Electronics Working Action Group (CEWAG), which is an initiative of GS1 Australia, is intended to help  

FDA Launches New 'Safe Use Initiative' to Reduce Medication Errors

I go to the U.S. Food and Drug Administration (FDA) website almost every day to glimpse their recent news releases. That’s because sometimes their announcements don’t seem to get much pick up in the usual places. Yesterday they issued this news release. The headline is: FDA Unveils Safe Use Initiative that Targets Preventable Harm from Medication...

GS1 Labeling Awareness Hits Top Executive Level Agenda

You know, when the subject of barcodes and product labels comes up in many executive suites, C-level executives have a tendency sometimes to tune out. They shouldn’t, of course, because a wrong barcode or an inability to produce labels can stop production and  

GS1 Releases GPC Codes for Drugs and Medical Devices

At this site, GS1 Healthcare has made the following announcement: To support the immediate  

Survey Estimates GS1 Adoption Can Bring $16 Billion Savings to Healthcare

There are so many voices in a recent news release, posted here by GS1 Healthcare US,  it is probably best just to give you the opening paragraph that summarizes everything:

'GS1 codes… less suitable for medical applications,' say two HIBCC Execs

[Editor's note: I have a view which differs from Sterling's even-handed one and certainly from the bias of the two gentlemen quoted below.